Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Neuroendocrine Tumors × Axitinib × Clear all

Sponsor

Conditions

Carcinoma, Renal Cell 21 Neoplasms 7 Kidney Neoplasms 7 Carcinoma, Non-Small-Cell Lung 7 Carcinoma 5 Melanoma 4 Lung Neoplasms 4 Neoplasm Metastasis 3 Colorectal Neoplasms 3 Thyroid Neoplasms 2 Kidney Diseases 2 Clear-cell metastatic renal cell carcinoma 2 Carcinoma, Hepatocellular 2 Uveal Melanoma 1 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Neoplasms 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Recurrence 1 Prostatic Neoplasms 1 Pheochromocytoma 1 Paraganglioma 1 Pancreatic Neoplasms 1 Neuroma, Acoustic 1 Neurofibromatosis 2 1 Myelodysplastic Syndromes 1 Leukemia, Myeloid, Acute 1 Glioblastoma 1

Interventions

Everolimus 13 Octreotide 6 Magnetic Resonance Spectroscopy 5 lanreotide 4 Sunitinib 4 gallium Ga 68 dotatate 3 cabozantinib 3 arginyllysine 3 Specimen Handling 3 Nivolumab 3 Etoposide 3 Carboplatin 3 Bevacizumab 3 telotristat ethyl 2 surufatinib 2 pembrolizumab 2 pazopanib 2 pasireotide 2 lutetium Lu 177 dotatate 2 X-Rays 2 Temozolomide 2 Phantoms, Imaging 2 Oxaliplatin 2 Ipilimumab 2 Erlotinib Hydrochloride 2 Doxorubicin 2 Cisplatin 2 Capecitabine 2 3-Iodobenzylguanidine 2 177Lu-DOTA-JR11 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡